#2 is a big fat yes imo. However, I don’t know that for a fact but everything I’ve seen so far points to that being a yes. I guess one could say the FDA is very incompetent or their is way too much bureaucracy involved. I’m not 100 percent sure as I do not work for the FDA. I could very well be wrong.

Regardless I believe there isn’t anything the FDA can do to stop Leronlimab from getting approval at some point for HIV or COVID. Too many people at this point know about Leronlimab and once the data is released there’s no hiding it from the public.

Let’s see how this plays out but I truly believe many hard working people at the FDA that want to see good things come out of this pandemic.